Scope
ISO 10816-3
Industrial Machine Vibration Assessment (>15 kW)
ISO 10816-3 specifies vibration evaluation criteria for industrial machines exceeding 15 kW output, measured on non-rotating structural parts at speeds between 120 and 15,000 r/min. This standard defines acceptance zones and diagnostic limits essential for commissioning and in-service monitoring of large industrial equipment. Plant operators, equipment manufacturers, and condition monitoring specialists rely on this test to detect developing mechanical faults and plan maintenance interventions. Accreditation guarantees standardised measurement practices that support production uptime and worker safety in industrial facilities across Europe.
What it measures
- Vibration velocity in mm/s (RMS) on bearing pedestals
- Measurement at specified speed ranges and operating conditions
- Zone classification (A: good, B: acceptable, C: just tolerable, D: unacceptable)
- Vertical and horizontal vibration components
- Trend analysis and transient response
🇩🇪
DIN EN ISO 10816-1
🇬🇧
BS EN ISO 10816-1
🇫🇷
NF EN ISO 10816-1
🇮🇹
UNI EN ISO 10816-1
🇪🇸
UNE EN ISO 10816-1
🇳🇱
NEN EN ISO 10816-1
🇩🇪
DIN EN ISO 20816-3
🇬🇧
BS EN ISO 20816-3
🇫🇷
NF EN ISO 20816-3
🇮🇹
UNI EN ISO 20816-3
🇪🇸
UNE EN ISO 20816-3
🇳🇱
NEN EN ISO 20816-3
1,817
Accredited labs
19
Countries
Showing 1,676–1,700 of 1,817 labs
ADP
Arachidonsäure
Kollagen/Epinephrin
Ristocetin
Expression aktivierungsabhängiger
+ 3 more
HbA1c
Aldosteron
Cortisol
APCR- Resistenz
Cardiolipin-AK IgG
+ 3 more
Universitätsklinikum des Saarlandes Institut für Klinische Hämostaseologie und Transfusionsmedizin
Active
freies Hämoglobin
Erythrozyten
Hämatokrit
Hämoglobin
Kleines Differential-Blutbild
+ 3 more
Urinsediment
Lamotrigin
HbA1c
Erythrozyten
Aripiprazol
+ 3 more
Familiäre Adenomatöse Polyposis
Syndrome (APC, MUTYH)
STK11, SMAD4 ), TruRisk® -Panel [SNV, CN
Familiäre Polyposis-Syndrome [FAP]
(APC, MUTYH)
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
Thrombozytenaggregation
Born
Verschlußzeit Kollagen/ADP
Verschlußzeit Kollagen/Adrenalin
6-Methyl-Mercaptopurinnukleotide
+ 3 more
angeborener Chromosomensatz
Molybdän-Cofaktor Defizienz
(MOCS1, MOCS2)
Fragiles X-Syndrom: FMR1
Spinocerebellare Ataxie (SCA)
+ 3 more
alpha-Aminobuttersäure
Mianserin
Arginin
Asparagin
Asparaginsäure
+ 3 more
Candida spp.-Antikörper
Cardiolipin-Antikörper
Meningitiserreger-Ag (E. coli
Staphylococcus aureus
Treponema pallidum-Antikörper
+ 3 more
Granulozytäre Antikörper
(Screening und Differenzierung)
HLA spezifische Antikörper
B-Streptokokken (Screening)
Ektoparasiten (Differenzierung)
+ 3 more
Anti-Thyreoglobulin-Antikörper
[Anti-TG]
Anti-Thyreoperoxidase Antikörper
[Anti-TPO]
Anti-TSH-Rezeptor Antikörper
+ 3 more
angeborener Chromosomensatz
Silver-Russell-Syndrom:
H19, KCNQ1OT1
MEST
Deletion; Angelman-Syndrom
+ 3 more
5-Hydroxyindolessigsäure
Amitriptylin/Nortriptylin
Cyclosporin A
Gesamt-Itraconazol
Metanephrine, Normetanephrine
+ 3 more
ISO 16750-3
IEC 60068-2-80)
IEC 60068-2-53 limitée à :
IEC 60068-2-14 fait
IEC 60068-2-1 et
+ 3 more
IEC 60061-1
IEC 60061-2
IEC 60238
IEC 61184
IEC 60400
+ 3 more
ASTM D3575
ASTM D642
DIN 55440-1
DIN EN ISO 12048
DIN EN ISO 2234
+ 3 more
(HSG 248) – 2021
ASB/10 based on HSG 248
(PCM) based on HSG 248
ASB/6 based on HSG 248
BS EN ISO 14644-1:2015
+ 3 more
Myopathie, Nemaline (TyP1, 3-10:
ASTM E 23-18
ASTM D 1322
Toxizität UGT1A1-Gen rs3064744, rs414832
DIN EN 1789
+ 3 more
VIRLAB
Active
IEC 60068-2-6
UNE-EN 60068-2-6
UNE-EN 60068-2-27
IEC 60068-2-27
UNE-EN 60068-2-57
+ 3 more
VITESS
Active
IEC 60529: 1989
IEC 60068-2-2
IEC 60068-2-30
IEC 60068-2-1
DIN EN 60529
+ 3 more
No matching labs found.